Skip to main navigation Skip to search Skip to main content

Ixazomib significantly prolongs progression-free survival in high-risk relapsed/refractory myeloma patients

  • Hervé Avet-Loiseau*
  • , Nizar J. Bahlis
  • , Wee Joo Chng
  • , Tamas Masszi
  • , Luisa Viterbo
  • , Ludek Pour
  • , Peter Ganly
  • , Antonio Palumbo
  • , Michele Cavo
  • , Christian Langer
  • , Andrzej Pluta
  • , Arnon Nagler
  • , Shaji Kumar
  • , Dina Ben-Yehuda
  • , S. Vincent Rajkumar
  • , Jesus San-Miguel
  • , Deborah Berg
  • , Jianchang Lin
  • , Helgi Van De Velde
  • , Dixie Lee Esseltine
  • Alessandra di Bacco, Philippe Moreau, Paul G. Richardson
*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

104 Scopus citations

Fingerprint

Dive into the research topics of 'Ixazomib significantly prolongs progression-free survival in high-risk relapsed/refractory myeloma patients'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology